← All people

Other insiders

Jonathan Wygant

Transactions disclosed by this reporting insider. Insider filers can be individuals or organisations.

Source last checked 2026-10-31 04:50 UTC. Reporting dates appear with the records.

Stock growth & value

Stocks linked to collected disclosures. Prices refresh in the background; the chart shows its actual price dates.

Latest stored close
$52.17
VCYT · 2026-10-29 · USD
Stock price change
+$16.09
+44.60% over the displayed dates
Chart dates
2025-10-31 – 2026-10-29
Completed daily price dates

Stock price · move across the chart or use arrow keys

Oct 31, 2025Oct 29, 2026
Starting investment
$10K
2025-10-31 · hypothetical
Investment value
$14.5K
As of 2026-10-29
Estimated gain / loss
+$4,459.53
+44.60%

Illustration assumes buying this stock at the first displayed close and holding through the last. It does not represent this person's investment or earnings. Uses stored split-adjusted closing prices, without dividends, fees or taxes. Only mapped USD share positions qualify for firm estimates; options, debt and unmapped holdings are excluded. This chart covers the selected stock.

Collected Form 4 activity · 2026-09-02 – 2026-10-28. Priced non-derivative purchases and sales, including scheduled trades; excludes grants, exercises and tax withholding. These totals do not change with the chart period.

Disclosed purchases
—
No priced purchase collected
Disclosed sales
—
No priced sale collected

2 transaction lines

SEC Form 4 records. Grants, exercises, tax withholding and scheduled sales retain their labels.

CompanyActionValue
VCYTVeracyte Inc2026-10-28
Withheld for tax
$65.7K
VCYTVeracyte Inc2026-09-02
Withheld for tax
$61.1K

Original sources

Related datasets